Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (Q1654244): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Created a new Item
 
ReferenceBot (talk | contribs)
Changed an Item
 
(6 intermediate revisions by 4 users not shown)
Property / describes a project that uses
 
Property / describes a project that uses: MEMSS / rank
 
Normal rank
Property / describes a project that uses
 
Property / describes a project that uses: S-PLUS / rank
 
Normal rank
Property / describes a project that uses
 
Property / describes a project that uses: Cubature / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2590308184 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3997739 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3445852 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Adaptive designs for dose-finding based on efficacy-toxicity response / rank
 
Normal rank
Property / cites work
 
Property / cites work: Model-oriented design of experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose finding in drug development. / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4699452 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal design in random-effects regression models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Mixed-Effects Models in S and S-PLUS / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding Based on Efficacy-Toxicity Trade-Offs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Analysis of Linear and Non-Linear Population Models by Using the Gibbs Sampler / rank
 
Normal rank
Property / cites work
 
Property / cites work: Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers / rank
 
Normal rank
links / mardi / namelinks / mardi / name
 

Latest revision as of 06:13, 16 July 2024

scientific article
Language Label Description Also known as
English
Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials
scientific article

    Statements

    Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (English)
    0 references
    0 references
    0 references
    0 references
    7 August 2018
    0 references
    area under the concentration curve
    0 references
    continuation ratio model
    0 references
    \(D\)-optimum sampling times
    0 references
    one-compartment pharmacokinetic model
    0 references
    population pharmacokinetics
    0 references
    0 references
    0 references
    0 references

    Identifiers